DEXTROSE INJECTION

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of one unit of Dextrose Injection (NSN 6505015015408) at a total price of $58.26, with an award date of July 20, 2026. The order is classified as a small business set-aside with specific woman-owned small business status, and the item must be delivered FOB destination to Scott Air Force Base, Illinois, with no quantity variance permitted. Shipment must be traceable and cannot be sent via parcel post, with all packaging and documentation required to clearly display both the base contract number SPE2DX-25-D-9900 and the delivery order number SPE2DP-26-F-7774 using block printing. Inspection and formal acceptance occur at the delivery point by the Government, specifically through contracting officer Lisa Quinn, with compliance based solely on adherence to the contract specifications for the product. Payment is processed through DFAS at Columbus, Ohio, using payment code SL4701 and appropriation line BX: 97X4930 5CBX 001 2620 S33189. The awardee has certified as a small business and woman-owned small business, triggering compliance obligations under FAR 19.101 and 19.150, though no formal clause listings from FAR or DFARS are provided in the document. The underlying contract vehicle is inferred to be an IDIQ, and while no detailed performance specifications, preservation requirements, or MIL-STD references are stated, the product is presumed to meet federal pharmaceutical standards in accordance with its nature and regulation. No options, multiple line items, or special terms beyond delivery, inspection, and certification conditions are included, and no attachments or Section M evaluation criteria are present, suggesting a streamlined, low-value procurement executed under established channels without competitive negotiation or trade-off analysis.